Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 53, 2023 - Issue 3
219
Views
4
CrossRef citations to date
0
Altmetric
Articles

Design, synthesis and anticancer activity of amide derivatives of substituted 3-methyl-benzofuran-2-carboxylic acid

, , , & ORCID Icon
Pages 217-233 | Received 08 Oct 2022, Published online: 23 Dec 2022
 

Abstract

We have designed and synthesized amide derivatives of substituted 3-methyl-benzofuran-2-carboxylic acid with aryl sulfonamide piperazines, aryl hydrazides and aryl hydrazines. All the synthesized compounds were screened for their anticancer activity against lungs cancer cell line (A549) and breast cancer cell line (MCF7) using MTT assay. Compound 12b showed excellent activity against lungs cancer cell line (A549) with IC50 value of 0.858 µM and compound 10d showed good activity against breast cancer cell line (MCF7) with IC50 value of 2.07 µM. Hence, compounds 10d and 12b were studied further for their mechanism of cytotoxicity by using EtBr/AO and LDH assay in respective cell lines. The cytostatic potential of compound 10d and 12b was uncurtail by Trypan blue exclusion assay and active involvement of ROS was quantified using DCFH-DA dye. The drug-likeliness and toxicity predictions were done using in-silico-based SwissADME and ProTox-II webserver, which confirmed negligible toxicity (Class IV).

GRAPHICAL ABSTRACT

Acknowledgments

Authors are thankful to The Head, Department of Chemistry and Department of Zoology, Faculty of Science, The M. S. University of Baroda for providing laboratory facilities, Zydus Research Centre, Ahmedabad, for the ESI-MS analyses. The authors are thankful to DST-FIST for NMR facility.

Additional information

Funding

One of the authors (JP) is thankful to Government of Gujarat for financial support vide reference [no. 202001720128] SHODH fellowship to carry out this work.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.